Investors / Cape Fear BioCapital
Cape Fear BioCapital
Venture capital
Cape Fear BioCapital is an early-stage venture capital firm that backs therapeutics companies emerging from North Carolina's research ecosystem. It writes first checks and joins syndicates, working with founders before most institutional capital is available.
Invests inHealthcare & Biotech
In its own wordstherapeuticsbiotechlife sciencesoncologyplatformnorth carolina
Your fit with Cape Fear BioCapital
Four questions about your startup
See how your round matches what it backs, point by point.
Or find every investor that fitsCape Fear BioCapital lists 5 checked portfolio companies on its own site and is named in 3 funding rounds. Its most frequent entry is Seed, 50% of the companies with a known first round. Its largest theme is Healthcare & Biotech (100%). 80% of its companies are based in United States. It invests most often alongside Hatteras Venture Partners, IndieBio and SOSV.
Counts come from funding rounds that name Cape Fear BioCapital, complete from mid-2025: earlier rounds appear only when they were reported later. Round amounts and full round histories are on Fundup AI.
Entry stage
share of companies by the stage of its first roundShow as a table
| Value | |
|---|---|
| Pre-seed | 0% |
| Seed | 50% |
| Series A | 0% |
| Series B | 50% |
| Growth | 0% |
Activity by year
rounds it joined, last 10 yearsShow as a table
| Total | Rounds it led | |
|---|---|---|
| '17 | 0 | 0 |
| '18 | 0 | 0 |
| '19 | 0 | 0 |
| '20 | 0 | 0 |
| '21 | 0 | 0 |
| '22 | 0 | 0 |
| '23 | 0 | 0 |
| '24 | 0 | 0 |
| '25 | 2 | 0 |
| '26 | 1 | 0 |
Investor profile
percentile among all firmsShow as a table
| Measure | Percentile of all firms | Value |
|---|---|---|
| Portfolio size | 4th | 5 companies |
| Recent activity | 59th | 1 rounds in 12 months |
| Early stage | 73th | 50% of entries at pre-seed or seed |
| Evidence | 100th | 60% of companies confirmed by a round |
| Sector focus | 100th | 100% in its largest sector |
| Reach | 42th | 2 countries |
Invests most often with
firms sharing its portfolio companiesShow as a table
| Share | |
|---|---|
| Hatteras Venture Partners | 2 |
| IndieBio | 2 |
| SOSV | 2 |
| Alix Ventures | 1 |
| Black Opal Ventures | 1 |
| Boxer Capital | 1 |
| Chugai Venture Fund | 1 |
| DFJ DragonFund | 1 |
Its portfolio companies
where they are based, and what their own sites showSite status
- Site answers5100%
- No longer answers00%
- Points to another company00%
- Parked or sold domain00%
A site that stops answering three checks in a row is counted as no longer answering; that is not proof of closure. A site that points to another company is often an acquisition.
Investment themes
share of its checked companiesThis firmAll checked companies
Show as a table
| This firm | All checked companies | |
|---|---|---|
| Healthcare & Biotech | 100% | 15% |
Co-investor network
who it backs companies with, and who they back togetherAll co-investors or Compare portfolios with Hatteras Venture Partners
Compare Cape Fear BioCapital head to head
portfolio size, rounds, entry stages, themes and the companies both backThree or more firms at once: portfolio overlap.
Recent portfolio activity
when companies last raised with Cape Fear BioCapital| Date | Company | Stage |
|---|---|---|
| 19 Feb 2026 | Round | |
| 29 Oct 2025 | Seed | |
| 25 Aug 2025 | Series B |
Round details for Cape Fear BioCapital
Amounts, full round histories and every co-investor in Cape Fear BioCapital's rounds are on Fundup AI. VCinfo covers investors and their portfolios.
Portfolio
5 companies checked against their own sites| Company | What it does | Themes | First round with it | Evidence |
|---|---|---|---|---|
| Eldec Pharmaceuticals discovers and optimizes peptides to create therapeutics for chronic lung diseases. | Healthcare & Biotech | Portfolio page | ||
| Incyclix Bio is a company advancing precision treatments that target the aberrant proliferation driving many cancers. | Healthcare & Biotech | Aug 2025Series B | Page + round | |
| The company creates human cells and organoids using a precision engineering platform for in vitro modeling and cell therapies. | Healthcare & Biotech | Oct 2025Seed | Page + round | |
| Ten63 Therapeutics designs therapeutics for diseases using generative chemistry and quantum-accurate simulation. | Healthcare & Biotech | Feb 2026Round | Page + round | |
| The company develops and provides medical equipment and devices to treat cardiothoracic diseases. | Healthcare & Biotech | Portfolio page |
About this data
site last read 5 Nov 2026- Site
- capefearbiocap.com
- Last read
- 5 Nov 2026
- Watching since
- 6 Nov 2026
- Rounds since
- 25 Aug 2025
- Companies checked
- 5
Rates come from what VCinfo has observed since observation_start. Firms tend to remove companies that closed, so early rates understate reality. A company leaving a portfolio page does not mean it closed or exited. An unreachable site means our checks failed, nothing more.
Get Cape Fear BioCapital's profile as data
Pull Cape Fear BioCapital's portfolio, co-investors and changes through one API key or MCP, open every portfolio row, compare it with other firms, and get an email when it adds a company or files a fund.
Work email, sign-in link by email. Already have an account? Log in- Ask AI5 plain-English investor searches a day
- Full listsEvery portfolio row and two-firm overlap
- API and MCP100 REST or MCP calls a month, one key
- AlertsFollow 5 investors for portfolio and fund changes
$ curl -H "X-API-Key: YOUR_KEY" \
https://api.vcinfo.io/v1/firms/capefearbiocap.com
# also
GET /v1/firms/capefearbiocap.com/portfolio
GET /v1/firms/capefearbiocap.com/coinvestors
GET /v1/firms/capefearbiocap.com/news